Xingcheng Wu

424 total citations
24 papers, 285 citations indexed

About

Xingcheng Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xingcheng Wu has authored 24 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Xingcheng Wu's work include Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Treatment and Research (5 papers) and Adrenal and Paraganglionic Tumors (5 papers). Xingcheng Wu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Treatment and Research (5 papers) and Adrenal and Paraganglionic Tumors (5 papers). Xingcheng Wu collaborates with scholars based in China and United States. Xingcheng Wu's co-authors include Zhien Zhou, Weigang Yan, Yi Zhou, Yu Xiao, Hanzhong Li, Guanghua Liu, Zhigang Ji, Yuzhi Zuo, Yi Zhou and Yu‐Zhong Yu and has published in prestigious journals such as Gene, Medicine and Investigative Ophthalmology & Visual Science.

In The Last Decade

Xingcheng Wu

21 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingcheng Wu China 9 172 169 56 56 34 24 285
Rongjie Zhao China 9 162 0.9× 102 0.6× 42 0.8× 56 1.0× 13 0.4× 21 279
Runyi Ye China 12 192 1.1× 142 0.8× 27 0.5× 45 0.8× 39 1.1× 15 306
Wei‐Jia Mo China 12 272 1.6× 208 1.2× 28 0.5× 76 1.4× 10 0.3× 30 352
Xinhong Wang China 11 246 1.4× 179 1.1× 25 0.4× 37 0.7× 9 0.3× 16 332
Chuanliang Xu China 9 152 0.9× 76 0.4× 50 0.9× 86 1.5× 18 0.5× 17 298
France‐Hélène Joncas Canada 7 201 1.2× 69 0.4× 30 0.5× 62 1.1× 12 0.4× 15 286
Zhendong Xiang China 13 302 1.8× 265 1.6× 26 0.5× 76 1.4× 14 0.4× 15 395

Countries citing papers authored by Xingcheng Wu

Since Specialization
Citations

This map shows the geographic impact of Xingcheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingcheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingcheng Wu more than expected).

Fields of papers citing papers by Xingcheng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingcheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingcheng Wu. The network helps show where Xingcheng Wu may publish in the future.

Co-authorship network of co-authors of Xingcheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingcheng Wu. A scholar is included among the top collaborators of Xingcheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingcheng Wu. Xingcheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Yu-Ting, Yu‐Zhong Yu, Tao Xie, et al.. (2025). TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway. Drug Resistance Updates. 81. 101227–101227. 2 indexed citations
2.
Wu, Xingcheng, Yali Xu, Xiaosong Wang, et al.. (2025). A Multi-phase CT Dataset for Automated Differential Diagnosis of Liver Tumors. Scientific Data. 13(1). 31–31.
3.
4.
Zuo, Yuzhi, Zhen Liang, Boju Pan, et al.. (2024). Clinical Characteristics of Adrenal Hemangioma. Journal of the Endocrine Society. 8(5). bvae041–bvae041. 2 indexed citations
5.
6.
Wu, Xingcheng, Yu‐Zhong Yu, Yuzhi Zuo, et al.. (2022). Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicity. Journal of Translational Medicine. 20(1). 91–91. 7 indexed citations
7.
8.
Chen, Yuliang, Zhien Zhou, Yi Zhou, et al.. (2021). Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy. BMC Urology. 21(1). 68–68. 3 indexed citations
9.
Zhou, Zhien, et al.. (2021). Long non‐coding RNA ADAMTS9‐AS1 inhibits the progression of prostate cancer by modulating the miR‐142‐5p/CCND1 axis. The Journal of Gene Medicine. 23(5). e3331–e3331. 18 indexed citations
10.
Zhao, Zhewei, et al.. (2019). Ureteral obstruction and hydronephrosis caused by foreign body. Medicine. 98(44). e17780–e17780. 1 indexed citations
11.
Tang, Mengling, Xingcheng Wu, Yuefen Cao, et al.. (2019). Preferential insertion of a Ty1 LTR-retrotransposon into the A sub-genome’s HD1 gene significantly correlated with the reduction in stem trichomes of tetraploid cotton. Molecular Genetics and Genomics. 295(1). 47–54. 10 indexed citations
12.
Wu, Xingcheng, et al.. (2019). Long noncoding RNA SNHG20 promotes prostate cancer progression via upregulating DDX17. Archives of Medical Science. 17(6). 1752–1765. 4 indexed citations
13.
Wu, Xingcheng, Yu Xiao, Yi Zhou, Zhien Zhou, & Weigang Yan. (2019). LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death and Disease. 10(7). 472–472. 97 indexed citations
14.
Zuo, Yuzhi, Xiaoxin Li, Xingcheng Wu, et al.. (2018). Multifocal Paraganglioma and Pheochromocytoma Due to Truncated SDHD Mutation. Urology. 116. 63–67. 1 indexed citations
15.
Li, Hanzhong, et al.. (2018). Open adrenalectomy versus laparoscopic adrenalectomy for adrenocortical carcinoma: a retrospective comparative study on short-term oncologic prognosis. OncoTargets and Therapy. Volume 11. 1625–1632. 27 indexed citations
16.
Zhou, Yi, Yumo Zhao, Xingcheng Wu, et al.. (2018). Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review. Frontiers in Endocrinology. 9. 165–165. 9 indexed citations
17.
18.
Li, Hanzhong, et al.. (2017). Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes. Medicine. 96(1). e5720–e5720. 8 indexed citations
19.
Chen, Peng, Yunhai Dai, Xingcheng Wu, et al.. (2014). Mutations in the ABCA3 Gene Are Associated With Cataract-Microcornea Syndrome. Investigative Ophthalmology & Visual Science. 55(12). 8031–8043. 17 indexed citations
20.
Mao, Jiangfeng, et al.. (2012). Recurrent Hypertensive Cerebral Hemorrhages in a Boy Caused by a Reninoma: Rare Manifestations and Distinctive Electron Microscopy Findings. Journal of Clinical Hypertension. 14(11). 802–805. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongjie Zhao Breakdown of academic impact, for papers by Runyi Ye Breakdown of academic impact, for papers by Wei‐Jia Mo Breakdown of academic impact, for papers by Xinhong Wang Breakdown of academic impact, for papers by Chuanliang Xu Breakdown of academic impact, for papers by France‐Hélène Joncas Breakdown of academic impact, for papers by Zhendong Xiang
Rankless by CCL
2026